| A Study of DS-9606a in Patients With Advanced Solid Tumors (NCT05394675) | Daiichi Sankyo | 2022-05-31 |
| Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor (NCT06470464) | Shandong First Medical University | 2021-11-11 |
| Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT (NCT04804007) | Nabil Adra | 2021-03-03 |
| Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children (NCT05179850) | West China Hospital | 2021-01-01 |
| A Study of miRNA 371 in Patients With Germ Cell Tumors (NCT04435756) | SWOG Cancer Research Network | 2020-07-28 |
| B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT04483778) | Seattle Children's Hospital | 2020-07-13 |
| Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children (NCT06341998) | Shandong First Medical University | 2020-06-01 |
| Symptom Management for YA Cancer Survivors (NCT04035447) | Duke University | 2020-01-22 |
| Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors (NCT04185038) | Seattle Children's Hospital | 2019-12-11 |
| EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT03618381) | Seattle Children's Hospital | 2019-06-18 |
| Disulfiram and Cisplatin in Refractory TGCTs. (NCT03950830) | National Cancer Institute, Slovakia | 2019-05-14 |
| EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors (NCT03638167) | Seattle Children's Hospital | 2019-03-19 |
| Study Evaluating the Impact of Short Message Service on Compliance With Surveillance of Patients With Germ-cell Tumors (NCT03868176) | Centre Hospitalier Universitaire de Besancon | 2019-02-28 |
| HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors (NCT03500991) | Seattle Children's Hospital | 2018-07-26 |
| Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS) (NCT03476070) | National University of Singapore | 2018-06-18 |
| Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy (NCT03418844) | Centre Francois Baclesse | 2018-05-07 |
| Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy (NCT03960151) | Costantine Albany | 2018-05-01 |
| Role of Axumin PET Scan in Germ Cell Tumor (NCT03426865) | University of Texas Southwestern Medical Center | 2018-03-01 |
| Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors (NCT03194906) | St. Jude Children's Research Hospital | 2017-11-07 |
| Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors (NCT03067181) | Children's Oncology Group | 2017-05-25 |
| Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors (NCT03158064) | Memorial Sloan Kettering Cancer Center | 2017-05-15 |
| Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors (NCT02988843) | Masonic Cancer Center, University of Minnesota | 2017-03-29 |
| Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies (NCT04308330) | New York Medical College | 2017-03-17 |
| Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors (NCT03081923) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2017-02-01 |
| Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) (NCT02624388) | University of Virginia | 2016-08-01 |
| Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors (NCT02375204) | Alliance for Clinical Trials in Oncology | 2015-08-06 |
| Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors (NCT02429466) | Nasser Hanna | 2015-04-27 |
| First Line TIP in Poor Prognosis TGCTs. (NCT02414685) | National Cancer Institute, Slovakia | 2015-04-01 |
| A Pilot RCT of the PRISM Intervention for AYAs With Cancer (NCT02340884) | Seattle Children's Hospital | 2015-01-30 |
| MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors (NCT02076906) | AeRang Kim | 2014-04-01 |
| Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours (NCT02582697) | University of Sydney | 2014-02-01 |
| Germ Cell Tumor and Testicular Tumor DNA Registry (NCT02099734) | Memorial Sloan Kettering Cancer Center | 2014-01-01 |
| A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas (NCT01625351) | St. Jude Children's Research Hospital | 2012-08-20 |
| Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors (NCT01966913) | Assistance Publique - Hôpitaux de Paris | 2012-04-01 |
| Establishing Prospective Mediastinal Tumor Database of PUMCH (NCT06421805) | Peking Union Medical College Hospital | 2012-01-01 |
| Everolimus in Refractory Testicular Germ Cell Cancer (NCT01466231) | National Cancer Institute, Slovakia | 2011-11-01 |
| Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors (NCT01331135) | Emory University | 2011-04-01 |
| Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors (NCT00983398) | OHSU Knight Cancer Institute | 2009-07-09 |
| Collecting and Storing Tissue From Young Patients With Cancer (NCT00898755) | Children's Oncology Group | 2007-03-05 |
| Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors (NCT00127049) | Gustave Roussy, Cancer Campus, Grand Paris | 2004-12-01 |
| CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant (NCT00369291) | Masonic Cancer Center, University of Minnesota | 2003-09-01 |
| Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors (NCT00198172) | Indiana University | 2000-10-01 |
| Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors (NCT00179816) | Ann & Robert H Lurie Children's Hospital of Chicago | 1999-04-01 |